Nath Bio-Genes Share Price

Nath Bio-Genes (INR)198.24-1.5   (-0.7%)

Exchange ScripsBSE537291NSENATHBIOGENISININE448G01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Nath Bio-Genes Performance

Market performance
Open price203.4
High204.38
Volumes19717
Prev Close198.24
Low197.05
Closing date2024-12-03
Historical performance
1 Year High264.31
3 Year High297.80
5 Year High473.95
1 Year Low167.15
3 Year Low128.85
5 Year Low127.30

Nath Bio-Genes Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
374
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
9.51
Dividend Yield
Dividend Yield
0.1 %

Nath Bio-Genes Investment Returns

1 Year
0.4%
3 Years
-23.7%
5 Years
-36.6%
10 Years
39.7%

Nath Bio-Genes Technicals

IndicatorsValueSignal
5-DMA192.69Bullish
10-DMA184.81Bullish
20-DMA184.37Bullish
50-DMA196.8Bullish
100-DMA212.75Bearish
200-DMA206.52Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1616161717
Foreign Investors---------------
Domestic Investors1616161717
Public Investors3540735818351163424634348
Government---------------

Nath Bio-Genes Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Other Income6619
Operating Profit506495391
Interest92104106
Depreciation333031
Profit Before Tax416362-634
Consolidated Net Profit396350-674
Adjusted EPS2118-35

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Share Capital190190190
Total Reserves590955425229
Minority Interest---------
Total Non-Current Liabilities793233
Total Liabilities880279287395
Capital Work in Progress---------
Total Assets880279287395

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Cash Flow from Operating Activities746384170
Cash Flow from Investing Activities-274-29-199
Cash Flow from Financing Activitie-78-17-222
Net Cash Inflow / Outflow394338-250
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 9.51.
  • 3Y Stock Price CAGR of the stock is -8.8.
  • The stock has a beta of 1.2.
  • In the last financial year, the company had an EBITDA of ₹506 Million.
  • The company generated revenue of ₹3326 Million in the previous financial year.

Nath Bio-Genes

198.24-1.5   (-0.7%)

Investment Amount: ₹ 19775
Current Value: ₹ 19824
Performence: 0.2%
P/L: ₹ 49
Top Gainers
SymbolChange%
JINDWORLD387.35(20%)
MCL63.84(20%)
BANG66.64(20%)
LINCOLN763.2(20%)
BSL285.77(19%)
Top Losers
SymbolChange%
PAR278.8(-20%)
GRANULES534.15(-10%)
AKI16.11(-10%)
MAPMYINDIA1538.1(-9%)
MALUPAPER48.24(-9%)
INDGN626.85(-6%)
STARPAPER227.82(-6%)
ZENTEC1806.4(-6%)
Similar stocks

Indo US Bio-Tech

14.1

312

November 3 - December 3

Agri-Tech (India)

4.4

208.94

November 3 - December 3

Narmada Agrobase

3.4

16.29

November 3 - December 3

Kaveri Seed

-0.3

917.55

November 3 - December 3

Bombay Super Hybrid

-3

162.55

November 3 - December 3

Venkys India

-4.8

1755.15

November 3 - December 3

Mangalam Global Ent

-4.9

23.91

November 3 - December 3

Harrisons Malayalam

-5.8

260.5

November 3 - December 3

Announcing Stock of the Month!

Stock of the Month
Stock of the Month